top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

​

Calla Lily joins $50m Wellcome Leap programme to advance targeted UTI treatment

London-based women’s health company will evaluate its Callavid drug delivery platform as part of a programme targeting antibiotic resistance.

 Featured Articles. 

7-format11240.jpg
​

Oxford and 2U Launch New Programme in AI-Driven Drug Discovery

Read More
7-format11240.jpg
PHARMA

Sanofi halts amlitelimab development for atopic dermatitis following pipeline review

Read More
7-format11240.jpg
HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

Read More
7-format11240.jpg
PHARMA

EyePoint’s DURAVYU misses first Phase 3 endpoint in wet AMD, putting focus on second trial

Read More
7-format11240.jpg
PHARMA

How Automation is Accelerating Drug Discovery Timelines

Read More
7-format11240.jpg
BIOPROCESSING

Bioreactors and Cell Culture Media: A Practical Comparison for Upstream Bioprocessing

Read More
7-format11240.jpg
PHARMA

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

Read More
7-format11240.jpg
BIOTECH

Using Jumping Genes for Safer, More Accurate DNA Editing

Read More
7-format11240.jpg
BIOTECH

Tecan Brings Agentic AI to the Lab Bench with NVIDIA-powered Introspect Upgrade

Read More

 Latest News. 

4th September, 2026

01.

Bio-Rad Expands Foresight Pro Chromatography Columns for Biomanufacturing

New prepacked process-scale columns broaden chromatography options for downstream purification of biopharmaceuticals.

Read More

2nd September, 2026

02.

Andelyn to Scale Manufacturing for Genprex’s Diabetes Gene Therapy Programme

AAV-based therapy targeting pancreatic cells moves towards IND-enabling studies and future clinical manufacturing.

Read More

25th August, 2026

03.

Carterra HT-SPR Helps Turn Anthropic’s Autonomous Protein Design Into Measurable Results

Carterra’s high-throughput SPR platforms help validate 1,320 AI-designed protein binders across 15 targets, highlighting the growing role of rapid experimental data in AI-driven drug discovery.

Read More

18th August, 2026

04.

EyePoint’s DURAVYU misses first Phase 3 endpoint in wet AMD, putting focus on second trial

EyePoint says an unusual imbalance in unrelated vision loss affected LUGANO results, while secondary data point to reduced treatment burden.

Read More

Editor's Selects.

AI in Science Writing and the Imitation of Understanding

01.

Read more

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

02.

Read more

A Simple Pad Could Transform Cervical Cancer Screening

03.

Read more

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

04.

Read more

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page